News tagged with cancer drug development
The gene processes that drive acute myeloid leukaemia
Researchers have described how the most common gene mutation found in acute myeloid leukaemia starts the process of cancer development and how it can cooperate with a well-defined group of other mutations to cause full-blown ...
Mar 27, 2011 |
not rated yet |
1
|
Researchers unravel protein's elusive role in embryo and disease development
Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune diseas ...
Medicine & Health / Medical research
Mar 02, 2011 |
5 / 5 (2) |
0
|
New strategies for cancer drug development urgently needed
Millions of cancer patients worldwide may soon be able to receive more effective, personalized treatments for their disease thanks to developments in the understanding of cancer biology, experts will say at the Cancer Biology ...
Nov 29, 2010 |
5 / 5 (1) |
0
'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer
A new oral drug caused dramatic shrinkage of a patient's rare, aggressive form of soft-tissue cancer that was driven by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute report in the ...
Oct 27, 2010 |
5 / 5 (1) |
0
UK cancer fund is not the victory for patient groups that some believe
The lead Editorial is this week's Lancet criticises the UK Government's announcement of an emergency cancer fund, and saying that is not the victory for patient groups that some believe.
Aug 05, 2010 |
3.5 / 5 (2) |
0
Down's Syndrome Chromosome Yields More Cancer-Blocking Genes
(PhysOrg.com) -- Scientists from Queen Mary, University of London have discovered cancer-blocking activity for genes carried on chromosome 21 - an extra copy of which is carried by people with Down’s syndrome.
Jun 11, 2010 |
5 / 5 (7) |
12
|
Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug
Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene within the short arm of chromosome 2 of their tumors had a much ...
Jan 13, 2010 |
not rated yet |
0
Texas begins $3 billion quest to cure cancer
(AP) -- Texas gave birth to the modern oil industry, invented the handheld calculator and sent man to the moon. But can the Lone Star State cure cancer?
Oct 02, 2009 |
not rated yet |
0
New cancer drug test promises safer and more effective clinical trials
A group of scientists from Hamburg may have taken a big step towards more effective cancer drug development, Europe's largest cancer congress, ECCO 15 - ESMO 34, heard today. Dr Ilona Schonn, Director of Cell Culture Research ...
Sep 23, 2009 |
not rated yet |
0
Expert calls for new cancer research priorities
Cancer research is too focused on new drug development, while not enough money and effort is being devoted to pursuing important advances in knowledge likely to have the biggest impact on combating the disease in the next ...
Sep 22, 2009 |
not rated yet |
0
Researchers find new molecule to block ‘Hedgehog’ signaling in cancer, development
(PhysOrg.com) -- Researchers have achieved a feat drug developers had thought difficult, if not impossible, discovering a compound that blocks the functioning of a key developmental protein by binding to an “undruggable” ...
Biology /
Jan 19, 2009 |
5 / 5 (2) |
0
